Unknown

Dataset Information

0

A clickable psoralen to directly quantify DNA interstrand crosslinking and repair.


ABSTRACT: DNA interstrand crosslinks (ICLs) represent physical obstacles to advancing replication forks and transcription complexes. A range of ICL-inducing agents have successfully been incorporated into cancer therapeutics. While studies have adopted UVA-activated psoralens as model ICL-inducing agents for investigating ICL repair, direct detection of the lesion has often been tempered by tagging the psoralen scaffold with a relatively large reporter group that may perturb the biological activity of the parent psoralen. Here a minimally-modified psoralen probe was prepared featuring a small alkyne handle suitable for click chemistry. The psoralen probe, designated 8-propargyloxypsoralen (8-POP), can be activated by UVA in vitro to generate ICLs that are susceptible to post-labeling with an azide-tagged fluorescent reporter via a copper-catalyzed reaction. A modified alkaline comet assay demonstrated that UVA-activated 8-POP proficiently generated ICLs in cells. Cellular 8-POP-DNA lesions were amenable to click-mediated ligation to fluorescent reporters in situ, which permitted their detection and quantitation by fluorescence microscopy and flow cytometry. Small molecule DNA repair inhibitors to 8-POP-treated cells attenuated the removal of 8-POP-DNA lesions, validating 8-POP as an appropriate probe for investigating cellular ICL repair. The post-labeling strategy applied in this study is inexpensive, rapid and highly modular in nature with the potential for multiple applications in DNA repair studies.

SUBMITTER: Evison BJ 

PROVIDER: S-EPMC4762217 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

A clickable psoralen to directly quantify DNA interstrand crosslinking and repair.

Evison Benjamin J BJ   Actis Marcelo L ML   Fujii Naoaki N  

Bioorganic & medicinal chemistry 20160118 5


DNA interstrand crosslinks (ICLs) represent physical obstacles to advancing replication forks and transcription complexes. A range of ICL-inducing agents have successfully been incorporated into cancer therapeutics. While studies have adopted UVA-activated psoralens as model ICL-inducing agents for investigating ICL repair, direct detection of the lesion has often been tempered by tagging the psoralen scaffold with a relatively large reporter group that may perturb the biological activity of the  ...[more]

Similar Datasets

| S-EPMC3786377 | biostudies-literature
| S-EPMC3642291 | biostudies-literature
| S-EPMC3516411 | biostudies-literature
| S-EPMC2583468 | biostudies-literature
| S-EPMC3666337 | biostudies-literature
| S-EPMC4285437 | biostudies-literature
| S-EPMC2748255 | biostudies-literature